Cytisinicline could offer adult cigarette smokers a potential new treatment option

FHS
July 11, 2023
11:23 pm

The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.

EMIS Triumphs with Innovation Award for Clinical Trial Recruitment Tool

Patient recruitment is a critical yet challenging phase in clinical trials. EMIS has been lauded for its significant contribution to this area with the Innovation

October 10, 2024

Quest inks deal for University Hospitals’ outreach lab services

Dive Brief: Quest Diagnostics said Wednesday it has agreed to buy University Hospitals’ outreach laboratory services business. University Hospitals is a nonprofit health system with

August 23, 2024

San Francisco Nurses Sue City Over Missed Breaks

Three nurses filed a class action lawsuit against the city and county of San Francisco last week, claiming they weren’t given legally mandated meal and

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.